Literature DB >> 22252772

Impact of a region wide antimicrobial stewardship guideline on urinary tract infection prescription patterns.

Celine Slekovec1, Joël Leroy, Nathalie Vernaz-Hegi, Jean-Pierre Faller, Danièle Sekri, Bruno Hoen, Daniel Talon, Xavier Bertrand.   

Abstract

BACKGROUND: Fluoroquinolones are frequently prescribed for non complicated urinary tract infection treatments and have a negative ecological impact. We aimed to substitute them by antibiotics with narrower activity spectrum in order to preserve fluoroquinolone activity in complicated hospital infections.
OBJECTIVE: To assess the impact of a multi-modal approach that combines the dispatching of antibiotic prescription guidelines and voluntary attendance at educational sessions on general practitioners' (GP) antibiotic prescription habits.
SETTING: This study was led in Franche-Comté, a French eastern region, where GPs were given a guideline recommending a restricted use of fluoroquinolones for urinary tract infections.
METHOD: Segmented regression analysis of interrupted time series was used to assess changes in antibiotic prescription. MAIN OUTCOME MEASURE: The antibiotic prescription data of nitrofurantoin, fosfomycin-trometamol and fluoroquinolones for women aged 15-65 years were obtained from the regional agency of health insurance.
RESULTS: Twenty months after intervention, the number of nitrofurantoin and fosfomycintrometamol prescriptions increased by 36.8% (95% CI: 30.6-42.2) and 28.5% (95% CI: 22.9-35.4), respectively, while that of norfloxacin decreased by 9.1% (95% CI: -15.3 to -3.5).
CONCLUSION: This study suggests that the dispatch of the guideline on urinary tract infection had a moderate impact on antibiotic prescriptions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22252772     DOI: 10.1007/s11096-012-9606-6

Source DB:  PubMed          Journal:  Int J Clin Pharm


  19 in total

1.  Outcomes of an intervention to improve hospital antibiotic prescribing: interrupted time series with segmented regression analysis.

Authors:  Faranak Ansari; Kirsteen Gray; Dilip Nathwani; Gabby Phillips; Simon Ogston; Craig Ramsay; Peter Davey
Journal:  J Antimicrob Chemother       Date:  2003-10-16       Impact factor: 5.790

2.  Effects of mailed dissemination of the Royal College of Radiologists' guidelines on general practitioner referrals for radiography: a time series analysis.

Authors:  L Matowe; C R Ramsay; J M Grimshaw; F J Gilbert; M-J Macleod; G Needham
Journal:  Clin Radiol       Date:  2002-07       Impact factor: 2.350

3.  Segmented regression analysis of interrupted time series studies in medication use research.

Authors:  A K Wagner; S B Soumerai; F Zhang; D Ross-Degnan
Journal:  J Clin Pharm Ther       Date:  2002-08       Impact factor: 2.512

4.  Physician compliance with mammography guidelines: barriers and enhancers.

Authors:  M E Costanza; A M Stoddard; J G Zapka; V P Gaw; R Barth
Journal:  J Am Board Fam Pract       Date:  1992 Mar-Apr

5.  [Regional audit on fluoroquinolones usage in the hospital and the community: are these antibiotics over-used?].

Authors:  J Leroy; I Patry; C Faure; E Ariskina; J-P Gaume; T Hénon; O Ruyer; J-P Faller; B Hoen; X Bertrand; D Talon
Journal:  Pathol Biol (Paris)       Date:  2009-11-05

6.  Pediatricians' awareness of and attitudes about four clinical practice guidelines.

Authors:  D A Christakis; F P Rivara
Journal:  Pediatrics       Date:  1998-05       Impact factor: 7.124

Review 7.  The ORION statement: guidelines for transparent reporting of outbreak reports and intervention studies of nosocomial infection.

Authors:  Sheldon P Stone; Ben S Cooper; Chris C Kibbler; Barry D Cookson; Jenny A Roberts; Graham F Medley; Georgia Duckworth; Rosalind Lai; Shah Ebrahim; Erwin M Brown; Phil J Wiffen; Peter G Davey
Journal:  Lancet Infect Dis       Date:  2007-04       Impact factor: 25.071

8.  Resistance of bacteria in urinary tract infections.

Authors:  M Chomarat
Journal:  Int J Antimicrob Agents       Date:  2000-12       Impact factor: 5.283

9.  Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991-2000.

Authors:  Marcus J Zervos; Ellie Hershberger; David P Nicolau; David J Ritchie; Lori K Blackner; Elizabeth A Coyle; Andrew J Donnelly; Stephen F Eckel; Robert H K Eng; Alexandra Hiltz; Arpi G Kuyumjian; William Krebs; Angee McDaniel; Patricia Hogan; Teresa J Lubowski
Journal:  Clin Infect Dis       Date:  2003-11-20       Impact factor: 9.079

10.  Fluoroquinolone use and methicillin-resistant Staphylococcus aureus isolation rates in hospitalized patients: a quasi experimental study.

Authors:  Pierre Charbonneau; Jean-Jacques Parienti; Pascal Thibon; Michel Ramakers; Cédric Daubin; Damien du Cheyron; Guy Lebouvier; Xavier Le Coutour; Roland Leclercq
Journal:  Clin Infect Dis       Date:  2006-02-07       Impact factor: 9.079

View more
  10 in total

Review 1.  Fosfomycin trometamol: a review of its use as a single-dose oral treatment for patients with acute lower urinary tract infections and pregnant women with asymptomatic bacteriuria.

Authors:  Gillian M Keating
Journal:  Drugs       Date:  2013-11       Impact factor: 9.546

2.  Antibiotic susceptibility testing in less than 30 min using direct single-cell imaging.

Authors:  Özden Baltekin; Alexis Boucharin; Eva Tano; Dan I Andersson; Johan Elf
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-08       Impact factor: 11.205

3.  Beyond antibiotic selection: concordance with the IDSA guidelines for uncomplicated urinary tract infections.

Authors:  M Kim; A Lloyd; M Condren; M J Miller
Journal:  Infection       Date:  2014-07-18       Impact factor: 3.553

4.  How Far We've Come, How Far We Have to Go: a Review of Advances in Antimicrobial Stewardship in the Veterans Health Administration.

Authors:  Aditi Ramakrishnan; Payal K Patel
Journal:  Curr Treat Options Infect Dis       Date:  2020-05-08

5.  Ambulatory Antibiotic Stewardship through a Human Factors Engineering Approach: A Systematic Review.

Authors:  Sara C Keller; Pranita D Tamma; Sara E Cosgrove; Melissa A Miller; Heather Sateia; Julie Szymczak; Ayse P Gurses; Jeffrey A Linder
Journal:  J Am Board Fam Med       Date:  2018 May-Jun       Impact factor: 2.657

6.  Low Concordance With Guidelines for Treatment of Acute Cystitis in Primary Care.

Authors:  Larissa Grigoryan; Roger Zoorob; Haijun Wang; Barbara W Trautner
Journal:  Open Forum Infect Dis       Date:  2015-10-26       Impact factor: 3.835

Review 7.  Effectiveness of Trainings of General Practitioners on Antibiotic Stewardship: Methods of a Pragmatic Quasi-Experimental Study in a Controlled Before-After Design in South-East-Lower Saxony, Germany (WASA).

Authors:  Daniela Gornyk; Martina Scharlach; Brigitte Buhr-Riehm; Carolina Judith Klett-Tammen; Sveja Eberhard; Jona Theodor Stahmeyer; Anika Großhennig; Andrea Smith; Sarah Meinicke; Wilfried Bautsch; Gérard Krause; Stefanie Castell
Journal:  Front Pharmacol       Date:  2021-04-22       Impact factor: 5.810

8.  Impact of Education and Data Feedback on Guideline-Concordant Prescribing for Urinary Tract Infections in the Outpatient Setting.

Authors:  Jason R Funaro; Rebekah W Moehring; Beiyu Liu; Hui-Jie Lee; Siyun Yang; Christina B Sarubbi; Deverick J Anderson; Rebekah H Wrenn
Journal:  Open Forum Infect Dis       Date:  2021-04-28       Impact factor: 3.835

9.  Higher third-generation cephalosporin prescription proportion is associated with lower probability of reducing carbapenem use: a nationwide retrospective study.

Authors:  Allison Muller; Xavier Bertrand; Anne-Marie Rogues; Muriel Péfau; Serge Alfandari; Rémy Gauzit; Catherine Dumartin; Houssein Gbaguidi-Haore
Journal:  Antimicrob Resist Infect Control       Date:  2018-01-22       Impact factor: 4.887

10.  Use of interrupted time series methods in the evaluation of health system quality improvement interventions: a methodological systematic review.

Authors:  Celestin Hategeka; Hinda Ruton; Mohammad Karamouzian; Larry D Lynd; Michael R Law
Journal:  BMJ Glob Health       Date:  2020-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.